Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcus Biosciences (RCUS) Revenue (2017 - 2025)

Historic Revenue for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to $26.0 million.

  • Arcus Biosciences' Revenue fell 4583.33% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $240.0 million, marking a year-over-year decrease of 874.52%. This contributed to the annual value of $258.0 million for FY2024, which is 12051.28% up from last year.
  • As of Q3 2025, Arcus Biosciences' Revenue stood at $26.0 million, which was down 4583.33% from $160.0 million recorded in Q2 2025.
  • Arcus Biosciences' 5-year Revenue high stood at $354.6 million for Q4 2021, and its period low was $9.5 million during Q1 2021.
  • For the 5-year period, Arcus Biosciences' Revenue averaged around $57.1 million, with its median value being $29.0 million (2023).
  • Per our database at Business Quant, Arcus Biosciences' Revenue skyrocketed by 363792.56% in 2021 and then tumbled by 9041.22% in 2022.
  • Arcus Biosciences' Revenue (Quarter) stood at $354.6 million in 2021, then crashed by 90.41% to $34.0 million in 2022, then fell by 8.82% to $31.0 million in 2023, then fell by 16.13% to $26.0 million in 2024, then changed by 0.0% to $26.0 million in 2025.
  • Its Revenue was $26.0 million in Q3 2025, compared to $160.0 million in Q2 2025 and $28.0 million in Q1 2025.